•  
  •  
  •  
  •  

2025-10-14 18:01:36

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Persistent Systems Ltd consolidated Q2FY26 net profit rises to Rs. 471.47 crores
  • Navkar Corporation Ltd Q2 FY2025-26 PAT at Rs. 4.35 crore
  • Bank of Maharashtra reports consolidated Q2FY26 PAT of Rs. 1633.50 crores
  • Automobile Corporation of Goa Ltd posts net profit of Rs. 14.63 crores in Q2FY26
  • Renaissance Global announces launch of Jean Dousset Jewelry's New Boutique in New York City

Keywords Selected:  INE700A01033

Stock Report

  • Jubilant HollisterStier LLC launches New High-Speed Isolator based Line, at its Spokane Manufacturing Facility in the US
  • Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Observations
  • Jubilant Pharmova Limited recommends final dividend of Rs. 5
  • Jubilant Cadista Pharmaceuticals Inc., USA's facility receives EIR from USFDA
  • Jubilant Cadista Pharmaceuticals Inc receives 5 observations from USFDA for Salisbury facility
  • USFDA Inspection at Jubilant HollisterStier General Partnership's Contract manufacturing facility at Montreal, Canada
  • Jubilant Pharmova announces completion of USFDA audit of facility Located at Spokane, Washington, USA
  • USFDA determines inspection classification of VAI for the contract manufacturing facility at Spokane, Washington
  • Jubilant Pharmova Ltd completes voluntary prepayment of USD 75 million term loan, equivalent to Rs. 626 Cr
  • Jubilant Pharmova announces completion of USFDA audit of contract manufacturing facility at Montreal, Canada
  • Jubilant's Radiopharma Business Announces Investment to Expand Positron Emission Tomography Radiopharmacy Network
  • Jubilant Pharmova Ltd announces voluntary prepayment of USD 75 million term loan, equivalent to Rs. 626 Cr
  • Jubilant Pharmova announces completion of USFDA audit of Radiopharmaceuticals manufacturing facility at Montreal, Canada
  • USFDA determines inspection classification of 'Voluntary Action Indicated' for the Solid dosage manufacturing facility at Roorkee, India
  • Jubilant Pharmova's wholly owned subsidiary to sell its entire 25.8% stake in Sofie Biosciences Inc., USA
  • Jubilant announces additional loan facility by Government of Canada for the Expansion of its CMO Montreal facility
  • USFDA assigns VAI classification to Jubilant Pharmova's API facility at Nanjangud
  • Jubilant's Radiopharma business receives NDA approval for Technetium Mertiatide Injection
  • USFDA completes inspection of Jubilant Pharmova's API Manufacturing Facility at Nanjangud, India
  • Jubilant Generics' Roorkee facility determined official action indicated
  • Jubilant receives EIR from USFDA for its radiopharmaceuticals manufacturing facility Montreal Canada
  • Jubilant Pharmova gets 6 observations from USFDA for its Solid Dosage Manufacturing Facility at Roorkee, India
  • USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list
  • Jubilant HollisterStier to expand its CMO manufacturing facility at Montreal, Canada

Latest Post

  • Persistent Systems Ltd consolidated Q2FY26 net profit rises to Rs. 471.47 crores
  • Navkar Corporation Ltd Q2 FY2025-26 PAT at Rs. 4.35 crore
  • Bank of Maharashtra reports consolidated Q2FY26 PAT of Rs. 1633.50 crores
  • Automobile Corporation of Goa Ltd posts net profit of Rs. 14.63 crores in Q2FY26
  • Renaissance Global announces launch of Jean Dousset Jewelry's New Boutique in New York City


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024